Page 78 - ITPS-7-1
P. 78

INNOSC Theranostics and
            Pharmacological Sciences                                     Docking study of quinoline-3-carbaldehyde derives



            26.  Huang H, Rong H, Li X, et al., 2008, The crystal structure   Drug Discovery: A  Guide for Medicinal Chemists and
               and identification of NQM1/YGR043C, a transaldolase   Pharmacologists. United States: John Wiley & Sons.
               from Saccharomyces cerevisiae. Proteins, 73: 1076–1081.   32.  Leung D, Abbenante G, Fairlie DP, 2000, Protease
               https://doi.org/10.1002/prot.22237                 inhibitors: Current status and future prospects. J Med Chem,
                                                                  43: 305–341.
            27.  Wang B, Yang, LP, Zhang XZ, et al., 2009, New insights into
               the structural characteristics and functional relevance of the      https://doi.org/10.1021/jm990412m
               human cytochrome P450  2D6 enzyme.  Drug Metab Rev,   33.  Barker BS, Young GT, Soubrane CH,  et al., 2017, Ion
               41: 573–643.                                       channels. In: Conn’s Translational Neuroscience. 1   ed.
                                                                                                         st
               https://doi.org/10.1080/03602530903118729          London: Elsevier Academic Press, p11–43.
            28.  Kakinuma T, Hwang, ST, 2006, Chemokines, chemokine      https://doi.org/10.1016/B978-0-12-802381-5.00002-6
               receptors, and cancer metastasis. J. Leukoc Biol, 79: 639–651.   34.  Ma FH, Li C, Liu YL, 2020, Mimicking molecular chaperones
               https://doi.org/10.1189/jlb.1105633                to regulate protein folding. Adv Mater, 32: e1805945.
            29.  McEwan IJ, 2009, Nuclear receptors: One big family. Methods      https://doi.org/10.1002/adma.201805945
               Mol Biol, 505: 3–18.                            35.  Savojardo C, Manfredi M, Martelli PL, et al., 2021, Solvent
                                                                  accessibility  of  residues  undergoing  pathogenic  variations
               https://doi.org/10.1007/978-1-60327-575-0_1
                                                                  in humans: From protein structures to protein sequences.
            30.  Schwab A, Fabian A, Hanley PJ,  et al., 2012, Role of ion   Front Mol Biosci, 7: 626363.
               channels and transporters in cell migration.  Physiol  Rev,      https://doi.org/10.3389/fmolb.2020.626363
               92: 1865–1913.
                                                               36.  Gromiha MM, Ahmad S, 2005, Role of solvent accessibility
               https://doi.org/10.1152/physrev.00018.2011
                                                                  in structure based drug design. Curr Comput Aided Drug
            31.  Copeland RA, 2013, Evaluation of Enzyme Inhibitors in   Des, 1: 223–235.














































            Volume 7 Issue 1 (2024)                         15                        https://doi.org/10.36922/itps.0976
   73   74   75   76   77   78   79   80   81   82   83